Research ExplorerPublicationsEarly transcatheter valve dysfunction after transapical mitr...

Early transcatheter valve dysfunction after transapical mitral valve-in-valve implantation

Standard

Early transcatheter valve dysfunction after transapical mitral valve-in-valve implantation. / Baldizon, Isabel; Espinoza, Andres; Kuntze, Thomas; Girdauskas, Evaldas.

In: INTERACT CARDIOV TH, Vol. 22, No. 4, 04.2016, p. 501-503.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Baldizon, I, Espinoza, A, Kuntze, T & Girdauskas, E 2016, 'Early transcatheter valve dysfunction after transapical mitral valve-in-valve implantation', INTERACT CARDIOV TH, vol. 22, no. 4, pp. 501-503. https://doi.org/10.1093/icvts/ivv377

APA

Baldizon, I., Espinoza, A., Kuntze, T., & Girdauskas, E. (2016). Early transcatheter valve dysfunction after transapical mitral valve-in-valve implantation. INTERACT CARDIOV TH, 22(4), 501-503. https://doi.org/10.1093/icvts/ivv377

Vancouver

Baldizon I, Espinoza A, Kuntze T, Girdauskas E. Early transcatheter valve dysfunction after transapical mitral valve-in-valve implantation. INTERACT CARDIOV TH. 2016 Apr;22(4):501-503. https://doi.org/10.1093/icvts/ivv377

Bibtex

@article{c44b8641eea9414281b0238945e81450,
title = "Early transcatheter valve dysfunction after transapical mitral valve-in-valve implantation",
abstract = "Some patients who underwent previous mitral valve surgery experience bioprosthetic valve degeneration or recurrent mitral valve regurgitation, and the transcatheter valve-in-valve or valve-in-ring procedure is a promising therapeutic option. Early thrombotic complications have been recently reported in 0.6-0.8% of TAVI prostheses implanted in aortic position. To the best of our knowledge, this article reports on the first case of thrombotic transcatheter mitral valve dysfunction which occurred on oral anticoagulation with Coumadin in combination with antiplatelet therapy. Although it is quite a rare complication, early thrombotic dysfunction of transcatheter valve prosthesis may occur. ",
keywords = "Administration, Oral, Aged, Anticoagulants/administration & dosage, Bioprosthesis, Cardiac Catheterization/adverse effects, Echocardiography, Transesophageal, Female, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation/adverse effects, Humans, Mitral Valve/diagnostic imaging, Platelet Aggregation Inhibitors/therapeutic use, Prosthesis Design, Prosthesis Failure, Thrombosis/diagnosis, Time Factors, Treatment Outcome, Warfarin/administration & dosage",
author = "Isabel Baldizon and Andres Espinoza and Thomas Kuntze and Evaldas Girdauskas",
note = "{\textcopyright} The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.",
year = "2016",
month = apr,
doi = "10.1093/icvts/ivv377",
language = "English",
volume = "22",
pages = "501--503",
journal = "INTERACT CARDIOV TH",
issn = "1569-9293",
publisher = "European Association for Cardio-Thoracic Surgery",
number = "4",

}

RIS

TY - JOUR

T1 - Early transcatheter valve dysfunction after transapical mitral valve-in-valve implantation

AU - Baldizon, Isabel

AU - Espinoza, Andres

AU - Kuntze, Thomas

AU - Girdauskas, Evaldas

N1 - © The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

PY - 2016/4

Y1 - 2016/4

N2 - Some patients who underwent previous mitral valve surgery experience bioprosthetic valve degeneration or recurrent mitral valve regurgitation, and the transcatheter valve-in-valve or valve-in-ring procedure is a promising therapeutic option. Early thrombotic complications have been recently reported in 0.6-0.8% of TAVI prostheses implanted in aortic position. To the best of our knowledge, this article reports on the first case of thrombotic transcatheter mitral valve dysfunction which occurred on oral anticoagulation with Coumadin in combination with antiplatelet therapy. Although it is quite a rare complication, early thrombotic dysfunction of transcatheter valve prosthesis may occur.

AB - Some patients who underwent previous mitral valve surgery experience bioprosthetic valve degeneration or recurrent mitral valve regurgitation, and the transcatheter valve-in-valve or valve-in-ring procedure is a promising therapeutic option. Early thrombotic complications have been recently reported in 0.6-0.8% of TAVI prostheses implanted in aortic position. To the best of our knowledge, this article reports on the first case of thrombotic transcatheter mitral valve dysfunction which occurred on oral anticoagulation with Coumadin in combination with antiplatelet therapy. Although it is quite a rare complication, early thrombotic dysfunction of transcatheter valve prosthesis may occur.

KW - Administration, Oral

KW - Aged

KW - Anticoagulants/administration & dosage

KW - Bioprosthesis

KW - Cardiac Catheterization/adverse effects

KW - Echocardiography, Transesophageal

KW - Female

KW - Heart Valve Prosthesis

KW - Heart Valve Prosthesis Implantation/adverse effects

KW - Humans

KW - Mitral Valve/diagnostic imaging

KW - Platelet Aggregation Inhibitors/therapeutic use

KW - Prosthesis Design

KW - Prosthesis Failure

KW - Thrombosis/diagnosis

KW - Time Factors

KW - Treatment Outcome

KW - Warfarin/administration & dosage

U2 - 10.1093/icvts/ivv377

DO - 10.1093/icvts/ivv377

M3 - SCORING: Journal article

C2 - 27002016

VL - 22

SP - 501

EP - 503

JO - INTERACT CARDIOV TH

JF - INTERACT CARDIOV TH

SN - 1569-9293

IS - 4

ER -